CRYOFLUOR THERAPEUTICS CLOSES SECOND-ROUND INVESTMENT

CryoFluor Therapeutics, a medical device company developing a novel cryosurgical technology platform, has received a second investment that will allow the company to complete a feasibility clinical trial of its device to treat abnormal uterine bleeding. Research Corporation Technologies, Endocare and Temple University participated in the investment.

Yahoo News (http://biz.yahoo.com/bw/050106/65787_1.html)